Svizera Labs Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-06-2024
- Paid Up Capital ₹ 2.80 Cr
as on 17-06-2024
- Company Age 27 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 88.84 Cr
as on 17-06-2024
- Revenue 14.76%
(FY 2021)
- Profit -111.25%
(FY 2021)
- Ebitda -46.78%
(FY 2021)
- Net Worth -1.44%
(FY 2021)
- Total Assets -14.26%
(FY 2021)
About Svizera Labs
The Corporate was formerly known as Trident Cleaning And Warehousing Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 2.80 Cr.
The company has closed loans amounting to ₹88.84 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Maneesh Sapte, Vinay Sapte, Pareshkumar Upadhyay, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH1997PTC107389
- Company No.
107389
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Apr 1997
- Date of AGM
11 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Svizera Labs?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Maneesh Sapte  | Director | 13-Nov-2000 | Current |
| Vinay Sapte | Director | 01-Apr-2002 | Current |
| Pareshkumar Upadhyay | Director | 28-Nov-2019 | Current |
| Rashmi Sapte | Director | 09-Apr-1999 | Current |
Financial Performance and Corporate Structure Insights of Svizera Labs.
Svizera Labs Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 14.76% increase. The company also saw a substantial fall in profitability, with a 111.25% decrease in profit. The company's net worth dipped by a decrease of 1.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Svizera Labs?
In 2023, Svizera Labs had a promoter holding of 100.00%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maneesh Pharmaceuticals LimitedActive 39 years 4 monthsManeesh Sapte, Vinay Sapte and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Citi Bank N.A. Creation Date: 30 Jun 2009 | ₹80.00 Cr | Satisfied |
Vijaya Bank Creation Date: 22 Dec 2005 | ₹3.00 Cr | Satisfied |
Vijaya Bank Creation Date: 28 Mar 2005 | ₹1.88 Cr | Satisfied |
How Many Employees Work at Svizera Labs?
Svizera Labs has a workforce of 60 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Svizera Labs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Svizera Labs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
